Delve deep into QRISK, the UK's prime tool for estimating an individual's 10-year risk for having a cardiovascular disease (e.g. heart attack or stroke)

Discover an in-depth exploration of cardiovascular disease (CVD), its risk factors, epidemiology, and prevention strategies.

Learn about types of lipids, their link to cardiovascular disease, normal lipid levels, and PocDoc's innovative 5-marker lipid test.

We're incredibly proud to be a partner of the Heart UK Annual Conference, taking place from 5th-7th July 2023 at the Oculus Building, University of Warwick.

PocDoc partners with NHS Targeted Lung Health Programme in North East, leveraging new biomarker Coronary Artery Calcium, to identify patients at increased risk of cardiovascular disease

PocDoc, the Cambridge-based digital health platform today announces it has launched in 4 major community pharmacy chains across the UK, giving it access to over 300 locations nationwide.

PocDoc Announces New £2.5M Fundraise for Digital Health Platform, Raising Seed Investment to £5M

PocDoc has been awarded a major contract to dramatically increase access to cholesterol testing outside of a traditional GP surgery environment. 

PocDoc has today announced the renewal of its partnership with PATH to jointly develop and the PocDoc Digital Reader for a number of Polio outbreak areas around the world.

PocDoc, the leading healthtech company, today reveals the majority (73%) of over 55s have never tested themselves for high cholesterol, despite nearly four fifths (79%) knowing it can lead to cardiovascular disease [CVD], which is often referred to as “heart disease”.

A strategic hire for PocDoc, Rob Barber brings his extensive experience in regulatory affairs to the innovative medical technology company.

PocDoc Selected for Global Heart Health Catalyst Biome Programme: A Leap Forward in Cardiovascular Care